Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Assets Average (2016 - 2025)

Historic Assets Average for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to $609.5 million.

  • Ocular Therapeutix's Assets Average rose 2853.88% to $609.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $609.5 million, marking a year-over-year increase of 2853.88%. This contributed to the annual value of $633.0 million for FY2025, which is 7831.0% up from last year.
  • Ocular Therapeutix's Assets Average amounted to $609.5 million in Q4 2025, which was up 2853.88% from $431.1 million recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Assets Average peaked at $609.5 million during Q4 2025, and registered a low of $125.6 million during Q2 2023.
  • For the 5-year period, Ocular Therapeutix's Assets Average averaged around $301.9 million, with its median value being $230.5 million (2021).
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 3037.54% in 2023, then skyrocketed by 32051.28% in 2024.
  • Over the past 5 years, Ocular Therapeutix's Assets Average (Quarter) stood at $211.3 million in 2021, then fell by 27.15% to $153.9 million in 2022, then skyrocketed by 34.62% to $207.2 million in 2023, then skyrocketed by 128.81% to $474.2 million in 2024, then grew by 28.54% to $609.5 million in 2025.
  • Its Assets Average stands at $609.5 million for Q4 2025, versus $431.1 million for Q3 2025 and $428.6 million for Q2 2025.